SYNTHESIS OF TEDANOLIDES CYTOTOXIC POLYPROPIONATES
泰丹内酯细胞毒性聚丙酸酯的合成
基本信息
- 批准号:2837715
- 负责人:
- 金额:$ 15.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1996
- 资助国家:美国
- 起止时间:1996-12-16 至 1999-11-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The purpose of this proposed research program is to develop new general
methods for the construction of polypropionate natural products. The key
step in the syntheses of these compounds involves a concerted Lewis acid-
promoted rearrangement of an optically active epoxy alcohol to generate
an 2-methyl-3-trialkylsilyloxy-alkanals, namely an aldol product by a
non-aldol route. We have shown that all four possible enantiomers can be
easily prepared in high optical purity and good yields by this approach.
We plan to extend this research to prepare polypropionate chains with
various absolute stereochemistries. In particular, in order to illustrate
the efficiency of this process, we will synthesize the two extremely
strongly cytotoxic agents, 13-deoxytedanolide 1 and tedanolide 2, and
their close structural analogues and diastereomers, by an application of
this new approach to polypropionates. 13-deoxytedanolide is extremely
cytotoxic [IC50 94 pg/ml (P388)] and has high antitumor activity [T/C
189% (P388) at 125 mug/kg] while tedanolide is also extremely tumor
inhibitory [ED50's 250 pg/ml (KB) and 16 pg/ml (PS)] and causes
accumulation of cells in the S phase at very low concentrations (10
ng/ml). Thus they are very promising leads as new agents for cancer
treatment. The development of good general routes for their synthesis
would not only provide a potentially useful preparation of them (both
were isolated from marine sponges and are present in very small
quantities) but also would allow one to prepare several structural
analogues unavailable from natural sources which may show enhanced
chemotherapeutic properties. We intend to make several analogues (e.g.,
the 13-epimer of 2, analogues with shorter side chain and ones with
different groups and/or stereochemistries). All of the advanced synthetic
materials will be tested for antitumor activity. In this way, we hope to
figure out just what parts of this complex molecule are required for the
potent antitumor activity and hopefully to prepare some simpler
structures which still show reasonable activity. The successful
accomplishment of the research described in this proposal - namely, the
development of a really useful synthetic route to polypropionates and the
synthesis of the potent cytotoxic agents 13-deoxytedanolide 1 and
tedanolide 2 and their analogues - would be of great significance to
medicinal chemistry. Because of the medicinal importance of the targets,
the efficiency of bond construction in the syntheses, and the high
intrinsic value of the new methods themselves, the likelihood of an
important contribution to health-related science is quite high.
这项拟议的研究计划的目的是开发新的通用
聚丙酸酯天然产物的构建方法。钥匙
在这些化合物的合成步骤中,涉及一种一致的Lewis酸-
促进光学活性环氧醇重排生成
2-甲基-3-三烷基硅氧基-烷烃,即由
非Aldol路线。我们已经证明,所有四种可能的对映体都可以是
该方法制备简单,光学纯度高,产率高。
我们计划将这项研究扩展到制备聚丙酸链
各种绝对的立体化学。特别是,为了说明
这个过程的效率,我们将把两者综合到极致
强细胞毒剂,13-脱氧萜内酯1和萜内酯2,以及
它们的紧密结构类似物和非对映异构体,通过应用
这种聚丙酸酯的新方法。13-脱氧戊二内酯是非常
细胞毒性[IC50 94 pg/ml(P388)],具有较高的抗肿瘤活性[T/C
125mug/kg时189%(P388),而tedanolide也是极具肿瘤性质的
抑制作用[ED50‘S 250 pg/ml(KB)和16 pg/ml(PS)]及其原因
极低浓度(10%)下S期细胞的积累
Ng/ml)。因此,它们是非常有希望成为治疗癌症的新药物的线索。
治疗。发展良好的合成路线
不仅提供了它们(两者)的潜在有用的准备
是从海绵中分离出来的,存在于非常小的
数量),但也将允许一个人准备几个结构
天然来源无法获得的类似物,可能会显示出增强的
化疗特性。我们打算制作几个类似物(例如,
2的13-同分异构体,侧链较短的类似物和带有
不同的群体和/或立体化学)。所有先进的合成材料
材料将进行抗肿瘤活性测试。通过这种方式,我们希望
找出这种复杂分子的哪些部分是
强大的抗肿瘤活性,希望能制备出一些更简单的
仍然显示出合理活动的结构。成功者
完成本建议中所述的研究--即
开发一种真正有用的合成聚丙酸酯的路线和
高效细胞毒剂13-脱氧戊二内酯1和2的合成
Tedanolide 2及其类似物-将具有重要意义
药物化学。因为靶子的药用价值,
在合成中键的构筑效率高,
新方法本身的内在价值,一种
对健康相关科学的重要贡献相当高。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL E JUNG其他文献
MICHAEL E JUNG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL E JUNG', 18)}}的其他基金
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10669717 - 财政年份:2020
- 资助金额:
$ 15.66万 - 项目类别:
SYNTHESIS OF TEDANOLIDES CYTOTOXIC POLYPROPIONATES
泰丹内酯细胞毒性聚丙酸酯的合成
- 批准号:
2010749 - 财政年份:1996
- 资助金额:
$ 15.66万 - 项目类别:
SYNTHESIS OF TEDANOLIDES CYTOTOXIC POLYPROPIONATES
泰丹内酯细胞毒性聚丙酸酯的合成
- 批准号:
2608152 - 财政年份:1996
- 资助金额:
$ 15.66万 - 项目类别:
SYNTHESIS OF THE TEDANOLIDES, CYTOTOXIC POLYPROPIONATES
细胞毒性聚丙酸酯泰丹内酯的合成
- 批准号:
6592046 - 财政年份:1996
- 资助金额:
$ 15.66万 - 项目类别:
SYNTHESIS OF THE TEDANOLIDES, CYTOTOXIC POLYPROPIONATES
细胞毒性聚丙酸酯泰丹内酯的合成
- 批准号:
6624727 - 财政年份:1996
- 资助金额:
$ 15.66万 - 项目类别:
SYNTHESIS OF THE TEDANOLIDES, CYTOTOXIC POLYPROPIONATES
细胞毒性聚丙酸酯泰丹内酯的合成
- 批准号:
6475903 - 财政年份:1996
- 资助金额:
$ 15.66万 - 项目类别:
SYNTHESIS OF THE TEDANOLIDES, CYTOTOXIC POLYPROPIONATES
细胞毒性聚丙酸酯泰丹内酯的合成
- 批准号:
6328962 - 财政年份:1996
- 资助金额:
$ 15.66万 - 项目类别:
SYNTHESIS OF THE TEDANOLIDES, CYTOTOXIC POLYPROPIONATES
细胞毒性聚丙酸酯泰丹内酯的合成
- 批准号:
6778026 - 财政年份:1996
- 资助金额:
$ 15.66万 - 项目类别:
SYNTHESIS OF THE TEDANOLIDES, CYTOTOXIC POLYPROPIONATES
细胞毒性聚丙酸酯泰丹内酯的合成
- 批准号:
2904802 - 财政年份:1996
- 资助金额:
$ 15.66万 - 项目类别:
相似海外基金
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
- 批准号:
10448926 - 财政年份:2021
- 资助金额:
$ 15.66万 - 项目类别:
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
- 批准号:
10491861 - 财政年份:2021
- 资助金额:
$ 15.66万 - 项目类别:
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
- 批准号:
10675535 - 财政年份:2021
- 资助金额:
$ 15.66万 - 项目类别:
EPSRC Centre for Doctoral Training in Bioprocess Engineering Leadership (Complex Biological Products Manufacture)
EPSRC 生物过程工程领导力博士培训中心(复杂生物制品制造)
- 批准号:
EP/S021868/1 - 财政年份:2019
- 资助金额:
$ 15.66万 - 项目类别:
Training Grant
Exploring interactions and benefits of novel microbial biological products in blueberry propagation
探索新型微生物生物制品在蓝莓繁殖中的相互作用和益处
- 批准号:
529840-2018 - 财政年份:2018
- 资助金额:
$ 15.66万 - 项目类别:
Applied Research and Development Grants - Level 1
GOALI: Collaborative Research: Industrial Implementation of Smart Biopolymers for Purification of Biological Products
目标:合作研究:用于生物制品纯化的智能生物聚合物的工业实施
- 批准号:
1403724 - 财政年份:2014
- 资助金额:
$ 15.66万 - 项目类别:
Standard Grant
GOALI: Collaborative Research: Industrial Implementation of Smart Biopolymers for Purification of Biological Products
目标:合作研究:用于生物制品纯化的智能生物聚合物的工业实施
- 批准号:
1403697 - 财政年份:2014
- 资助金额:
$ 15.66万 - 项目类别:
Standard Grant
Formulation and delivery approaches for water soluble biological products delivered through the skin focussing on L-Ascorbic Acid.
通过皮肤输送的水溶性生物产品的配方和输送方法,重点是 L-抗坏血酸。
- 批准号:
131690 - 财政年份:2014
- 资助金额:
$ 15.66万 - 项目类别:
Feasibility Studies
Formulation and stability of biological products for skin delivery focussing on Retinol.
以视黄醇为重点的皮肤输送生物制品的配方和稳定性。
- 批准号:
131338 - 财政年份:2013
- 资助金额:
$ 15.66万 - 项目类别:
Feasibility Studies
Demonstrate the effectiveness of antimicrobial protection of new types of Biological Products
展示新型生物制品抗菌保护的有效性
- 批准号:
429734-2011 - 财政年份:2012
- 资助金额:
$ 15.66万 - 项目类别:
Experience Awards (previously Industrial Undergraduate Student Research Awards)














{{item.name}}会员




